Erin Daly is TCS’s new Senior Manager of Intellectual Property, Life Sciences.  She is responsible for managing and growing the life sciences patent portfolio within the university.  Erin holds a juris doctorate from Suffolk University Law School and is also a registered patent practitioner with the United States Patent and Trademark Office.

Prior to joining UConn, Erin worked for eight years as a patent technology specialist. Her focus had been on drafting and prosecuting domestic and foreign patent applications related to pharmaceuticals, biopharmaceuticals, chemical processes, drug delivery, chemical formulations, and crystallography. Exemplary technologies include novel chemical entities, including antibody-drug conjugates, polymers, lipid nanoparticles, isotopically-labelled compounds, oligomers, and small molecules; solid forms of compounds, such as crystalline polymorphs; methods of organic synthesis, and methods of treating various types of cancer, microbial infections, pain, stroke, and Alzheimer’s disease.

Erin also has extensive experience in organic and medicinal chemistry research. She completed her postdoctoral studies in the Guy laboratory, St. Jude Children’s Research Hospital in Memphis, Tennessee, where her project was directed towards developing novel therapeutic agents for targeting the assembly of the transcriptional activation complex by the androgen nuclear hormone receptor.

Prior to her postdoctoral work, Erin earned a Ph.D. in the laboratory of Professor Richard E. Taylor at the University of Notre Dame where her dissertation studies provided biophysical evidence for the bioactive conformation of the epoxide/olefinic region of the epothilone class of natural products.

“I really love intellectual property law because of the juxtaposition of the law and science. Some of the best parts about this job are collaborating with top tier researchers in their field and (in a tangential way) being a part of their science by helping them obtain a patent.  I think UConn is a fantastic institution with some of the best minds in the U.S. and maybe the world. I am really looking forward to working with them!”